Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2018-07-02 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于收到药品注册批件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1250 characters) from a company about receiving a drug registration approval from the National Medical Products Administration (国家食品药品监督管理总局). It contains no financial data, no detailed financial statements, nor any discussion of financial results or management analysis. It is an official notice about regulatory approval of a pharmaceutical product. The document is not a report, but an announcement of a regulatory event related to product registration. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-07-02 Chinese
关于高级管理人员股份减持计划的预披露公告
Director's Dealing Classification · 100% confidence The document is a pre-disclosure announcement regarding a senior management personnel's plan to reduce their shareholding in the company. It details the shareholder's identity, the number of shares to be reduced, the method, timing, and legal compliance of the share reduction plan. This is a report of a personal share transaction by a company director/executive, which fits the definition of Director's Dealing (DIRS). The document is short and focused on insider share transactions, not a full financial report or other types of filings.
2018-06-29 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the shareholder involved, and the pledge's purpose. There is no financial report, earnings data, or management discussion. The content fits the category of a capital or financing update, specifically about share pledging, which affects the company's capital structure. Therefore, the document is best classified as a Capital/Financing Update (CAP). The document length is short and focused on this specific event, not a report publication or regulatory filing. Confidence is high due to clear content matching the CAP category.
2018-06-27 Chinese
关于控股股东部分股份质押及解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the pledge and release of shares by a controlling shareholder. It details the number of shares pledged, the dates, the pledgees, and the proportion of shares involved. There is no financial performance data, no mention of annual or quarterly reports, no discussion of management changes, or other report types. The content fits the description of a share pledge or capital structure update. Therefore, the document is best classified as a Capital/Financing Update (CAP). The document length is short and focused on share pledge information, confirming this classification with high confidence.
2018-06-22 Chinese
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the pledgee, and the proportion of shares pledged relative to total holdings and total share capital. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledging activity, which fits the category of a Regulatory Filing (RNS) as it does not fit into more specific categories like Capital/Financing Update or Major Shareholding Notification, since it is about share pledge rather than ownership change or capital raising.
2018-06-21 Chinese
第三届监事会第二十次会议决议公告（通讯表决方式）
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed at a supervisory board meeting, specifically about the election of a new chairman of the supervisory board following a resignation. It includes details about the meeting date, attendance, voting results, and compliance with company law and articles of association. There is no financial data, no mention of annual or interim reports, no audit information, no earnings data, and no investor presentation content. The document is clearly an announcement related to board/management changes, specifically the supervisory board chairman election. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a report or regulatory filing. Confidence is high due to clear content and context.
2018-06-08 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.